Katya Naidu24 Nov 2023, 10:14
The September quarter saw pharma companies clock double digit revenue growth, even as the sector continues to battle a range of issues in North America, which is their largest export market. Listed pharmaceutical companies reported average revenue growth of between 14 and 15% in the September quarter, thanks to price stabilization in the US generics market. While most analysts expect the trend to sustain for the rest of the financial year, a few also fear that pricing pressures might come back to hit India pharma sector.